Heparan sulfate (HS) has been found associated with amyloid deposits, including the toxic amyloid-beta (Aβ) peptide aggregates in cerebral vasculature and neuronal tissues in patients with Alzheimer's disease. However, the pathophysiological significance of the HS-Aβ interaction has remained unclear. In the present study, we applied cell models to gain insight into the roles of HS in relation to Aβ toxicity. Wild-type Chinese hamster ovary (CHO-WT) cells showed loss of viability following exposure to Aβ40, whereas the HS-deficient cell line, pgsD-677, was essentially resistant. Immunocytochemical analysis showed Aβ internalization by CHO-WT, but not pgsD-677 cells. Aβ40 toxicity was also attenuated in human embryonic kidney cells overexpressing heparanase. Finally, addition of heparin to human umbilical vein endothelial cells prevented internalization of added Aβ40 and protected against Aβ toxicity. Taken together, these findings suggest that cellsurface HS mediates Aβ internalization and toxicity.
Introduction
The amyloid-beta (Aβ) peptide deposits in Alzheimer's disease (AD) brain as senile plaques and cerebral amyloid angiopathy (CAA), pathologies that are respectively associated with neuronal and vascular degeneration. Heparan sulfate (HS) and HS proteoglycans (HSPGs) colocalize with Aβ in brains of AD patients and transgenic animals overexpressing mutant human amyloid-beta precursor protein (AβPP) (O'Callaghan et al. 2008; Snow et al.1988; Snow et al. 1994; van Horssen et al. 2001; van Horssen et al. 2003) . HSPGs are ubiquitous on cell surfaces and in the extracellular matrix, with diverse functions in development and homeostasis. Recent studies also implicate HSPGs in various pathophysiological settings, including inflammation, tumor metastasis and amyloidosis (Bishop et al. 2007; Li et al. 2005; Parish 2006 ). HSPGs consist of a core protein to which a number of negatively charged HS polysaccharide chains are covalently attached. The HS side chains can bind and interact with a wide range of protein ligands including Aβ (Lindahl and Li 2009; Lindahl et al. 1999) . The ligand-binding properties of HS depend on its structure, in particular the number and location of sulfate groups along the polysaccharide chain. The complex and variable HS structures are generated through a biosynthetic machinery that is regulated to provide domain-type, tissue/ cell-specific sulfate distribution patterns (Ledin et al. 2004) .
The predominant Aβ constituents of senile plaques in AD brain are the -40 (Aβ40) and -42 (Aβ42) residue forms, cleaved from AβPP by β-and γ-secretase (Selkoe 2001) . Initial studies implicated insoluble fibrils of Aβ as the principal neurotoxic form of the peptide (Lorenzo and Yankner 1994) . The fibrils induce apoptosis of cells (Loo et al. 1993) , resulting in dysfunction and degeneration. Emphasis has lately shifted towards soluble oligomers of Aβ, levels of which are increased ∼70-fold in brains of AD patients relative to controls (Gong et al. 2003) . Extracellular accumulation of 56-kDa soluble Aβ assemblies was recently implicated with memory impairment in middle-aged APP/Tg 2576 mice prior to the appearance of plaques (Lesne et al. 2006) . Furthermore, Aβ42 dimers and trimers are suggested to cause disruption of cognitive functions (Cleary et al. 2005) . Different therapeutic strategies for AD have been proposed to reduce the level of toxic forms of Aβ peptide in the brain. These include immunotherapies with antibodies against different forms of Aβ peptides (Geylis and Steinitz 2006) .
By and large, the mechanism(s) behind Aβ toxicity and the potential involvement of HS in the pathological process remains elusive. In the present study, our primary goal was to investigate the functional role of HS in Aβ cytotoxicity. By applying cell lines that either lack HS or produce truncated HS chains, we found a dependence of Aβ toxicity on expression of HS, which correlated with Aβ uptake. These findings demonstrate that cellular HS facilitates Aβ internalization and cytotoxicity.
Results

Aβ cell toxicity and internalization are HS-dependent
To assess the role of cellular HS in Aβ-induced cytotoxicity, we used two well-established Chinese hamster ovary (CHO) cell lines, pgsD-677 that is defective in HS biosynthesis (Lidholt et al. 1992 ) and wild-type [wild-type Chinese hamster ovary (CHO-WT)] cells. We first confirmed that the pgsD-677 cells maintained in our laboratory lacked HS, by metabolic labeling of the cells with [ 35 S]sulfate followed by analysis of the glycosaminoglycans (GAGs) isolated from the cells. The CHO-WT cells yielded both labeled HS and chondroitin sulfate, while the pgsD-677 mutant cells produced chondroitin sulfate only ( Figure 1A ) as previously described (Lidholt et al. 1992 ). Both cell types were exposed to aggregated Aβ40 (a-Aβ40) and aggregated-agitated Aβ40 (aa-Aβ40), containing variously aggregated peptide (Supplementary Figure 1) . Analysis of CHO-WT cells by the MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) reduction assay (Mosmann 1983) showed that both peptide preparations induced significant loss of viability (Figure 1B and C) . In contrast, the HS-deficient pgsD-677 cells were virtually resistant to Aβ40.
Uptake and intracellular distribution of a-Aβ40 was evaluated by immunostaining the cells with anti-Aβ (6E10) antibody in combination with a biotin-conjugated anti-mouse secondary antibody. Substantial Aβ-positive staining was found in CHO-WT cells, throughout the cell body ( Figure 1B ; CHO-WT) and in perinuclear locations ( Figure 1B ; arrow in upper panels). The HS-deficient pgsD-677 cells showed only traces of Aβ positive staining ( Figure 1B ; pgsD-677). Moreover, this staining differed qualitatively from that observed in CHO-WT cells. While Aβ distribution in CHO-WT was extensive, with a granular appearance, it appeared as a few compact fragments in pgsD-677 cells ( Figure 1B ; arrow in lower panels). Notably, only weak aa-Aβ40 signals were detected within CHO-WT cells (data not shown) despite confirmed susceptibility to treatment ( Figure 1C ). An explanation for this is that the conformation of the high molecular weight (MW) aggregates in this preparation ( Supplementary Figure 1) masks the Aβ epitopes of the anti-Aβ antibodies used. Alternatively, aa-Aβ40 may affect cell viability from an extracellular location, but appears nonetheless reliant on cellular HS.
Current evidence suggests that Aβ peptides induce neurotoxicity in their intermediate oligomeric state rather than as monomers or fibrils (Demuro et al. 2005) . Preparations of na-Aβ40 (nonaggregated Aβ40), composed largely of monomeric and low MW aggregates (Supplementary Figure 1) , were applied to experiments correlating peptide internalization with cytotoxicity. MTT analysis revealed that na-Aβ40 also had a substantial toxic effect on CHO-WT cells, whereas pgsD-677 cells were only marginally affected (Figure 2A ), similar to the results obtained with the more aggregated forms of the peptide (Figure 1 ). Toxicity showed modest dose dependency, over a wide range of Aβ concentrations.
Cytotoxicity was also assessed with annexin Vand propidium iodide (PI) staining, quantified by flow cytometry. Proportions of viable cells decreased from 92% to about 70% ( Figure 2B , upper panels, bottom left quadrants) after exposure to ≤5 µM a-Aβ40. Most of the nonviable cells (∼20% of total cell populations) stained positively for annexin V only (bottom right quadrants) indicative of early apoptosis, whereas ∼7% of the cells were annexin V and PI positive (top right quadrants) indicative of late apoptosis/necrosis. Again, the HS-deficient pgsD-677 cells appeared unaffected by Aβ treatment ( Figure 2B , lower panels). It is notable that the MTT assay revealed greater decreases in the percentage of viable cells than the annexin V/PI apoptosis assay (Figure 2A ). Metabolically impaired cells reduce less MTT and therefore a decrease in cell viability can be detected prior to apoptosis. To be detected by the annexin V/PI apoptosis assay, cells must have initiated apoptosis. Consequently, the MTT assay will record greater changes in the overall well-being of a cell population, while the annexin V/PI assay differentiates between early and late apoptotic states. 
Heparan sulfate mediates Aβ cytotoxicity
Image analysis (see Materials and methods) of cells immunostained with anti-Aβ antibody (82E1) visualized with a fluorescent secondary antibody confirmed that nonaggregated Aβ (na-Aβ) was internalized by CHO-WT cells in a dose-dependent manner, but was essentially undetectable in pgsD-677 cells ( Figure 2C ). The toxic effect and peptide internalization showed positive correlation. Although toxicity was also observed in the cells treated with 0.1 μM of na-Aβ40 (Figure 2A , CHO-WT), this concentration was below the detection threshold for intracellular immunostaining. In the absence of Aβ, nuclei were intact, rounded and bright (Figure 2C , insert; 0 µM na-Aβ), whereas na-Aβ treatment resulted in fading, fragmentation and severe condensation of nuclei, indicative of a distressed state of the cells (Figure 2C , inserts; 1, 5, 10 µM na-Aβ). CHO-WT exposure to na-Aβ had little effect on membrane integrity as indicated by a ∼3% increase in PI staining ( Figure 2B , CHO-WT; 1 and 5 μM panels), consequently the extensive intracellular staining observed in the majority of CHO-WT cells ( Figure 2C ) is likely due to HS-mediated uptake and not increased membrane permeability. Confocal laser scanning microscopy confirmed the intracellular location of Aβ in CHO-WT cells incubated for 16 h with 5 μM na-Aβ (immunostained with anti-Aβ antibody 6E10) ( Figure 2D ). A sequence of z-scan frames (each 1 μm thick) through a representative cell revealed Aβ wrapped around the entire nucleus ( Figure 2D ; panels 1-6). The association of Aβ with the nucleus is highlighted in a cross-sectioned 3D z-stack of the six frames ( Figure 2D ; 3D image). Taken together, these findings indicate that cellular HS mediates uptake and toxicity of Aβ peptide.
Heparanase overexpression attenuates Aβ40 toxicity in HEK293 cells
Human embryonic kidney cells (hpa-HEK293) overexpressing human heparanase (Nasser et al. 2005 ) generated shorter HS chains than mock-transfected cells (mock-HEK293) ( Figure 3A ). Upon incubation with na-Aβ40 or aa-Aβ40, the mock-transfected cells expressing normal HS chains were clearly susceptible to Aβ treatment ( Figure 3B ), similar to the CHO-WT cells (Figures 1 and 2 ), essentially irrespective of the Aβ aggregation state. In contrast, the effect of Aβ on the heparanase-overexpressing hpa-HEK293 cells, with truncated HS chains, was modest at all conditions investigated. The interpretation of these findings is not entirely straightforward, since heparanase overexpression may affect cell-surface HSPGs as well as release of HS fragments (see Discussion).
Heparin attenuates Aβ40 toxicity in HUVEC Heparin full-size chains and oligosaccharides were applied to HUVEC (human umbilical vein endothelial cells) cultures in experiments designed to examine effects of soluble saccharide on Aβ toxicity and uptake. Cells were treated with aggregated Aβ peptide (a-Aβ40) for 24 h. Cytotoxicity was assessed by flow cytometry, after staining with annexin V and PI. Cell viability decreased from 90% to 54% after exposure to ≤500 nM a-Aβ40 ( Figure 4A ). As for CHO-WT cells ( Figure 2B) , most of the nonviable cells (25-30% of total cells) appeared to be in an early apoptotic state, as they stained positively for annexin V only ( Figure 4A , bottom right quadrants), whereas 10-13% of the cells were in a late apoptotic/necrotic state as confirmed by both annexin V and PI staining ( Figure 4A , top right quadrants). When the HUVEC cultures were exposed to 50 nM or 500 nM a-Aβ40 that was preincubated with 1 µM heparin (a mean MW of 15 kDa, corresponding to ∼50 sugar units) for 1 h, the percentage of viable cells increased from 62% to 75% and from 54% to 75%, respectively ( Figure 4A , lower panels). Similar effects were seen when heparin was added to the cells together with a-Aβ40 without preincubation (data not shown). Cytotoxicity of a-Aβ40 as well as the attenuating effect of heparin was confirmed using the MTT reduction assay ( Figure 4B ). The protective effect of heparin against Aβ cytotoxicity was thus demonstrated by two independent methods. Notably, this effect was size-dependent, as 12-mer and smaller heparin fragments were unable to attenuate Aβ40-induced toxicity ( Figure 4B ).
Uptake of a-Aβ40 by HUVEC was examined by immunostaining with the anti-Aβ antibody 6E10. In the absence of heparin, strong intracellular Aβ40 immunosignal was detected in several areas surrounding the nuclei ( Figure 4C, left panel) . In contrast, cells cultured with a-Aβ40 in the presence of heparin showed greatly reduced peptide uptake ( Figure 4C , 536 
Discussion
HSPGs have been variously implicated with toxic effects of Aβ peptides. It has been reported that interaction of Aβ with cell-surface HS activates microglia to kill neurons (Giulian et al. 1998 ). Accordingly, we recently identified the cell-surface HSPGs, syndecan-3 and glypican-1, on reactive glial cells as probable sources of HS accumulated with the Aβ core of neuritic plaques (O'Callaghan et al. 2008 ). Aβ40 is the major component in CAA usually deposited close to the basement membrane in capillaries, arteries and veins where Aβ40 affects smooth muscle cells leading to hemorrhage and necrosis (Thal et al. 2008) , and was found to decrease the viability of these cells by disrupting interactions with the extracellular matrix HSPG, perlecan (Mok et al. 2006 ). Yet another proposal implies that Aβ reduces viability of endothelial cells, suppressing their angiogenic properties, by interfering with growth factor signaling (Donnini et al. 2006 ). In fact, we previously demonstrated common binding sites for Aβ fibrils and FGF2 in HS from human cerebral cortex (Lindahl et al. 1999) . Moreover, it has been suggested that Aβ exerts its toxicity intracellularly (Gouras et al. 2000; Wirths et al. 2004 ). Our present results concur with this concept, as both toxicity and internalization of Aβ were found to depend on HS in CHO cells (Figures 1 and 2) . HS-deficient pgsD-677 cells were essentially resistant to Aβ toxicity and did not internalize the peptide, in contrast to wild-type CHO-WT cells with intact HS biosynthesis.
Notably, this study does not exclude the possibility that Aβ-induced cell death and Aβ internalization occur independently of each other. Such an interpretation warrants consideration as uptake of <1 μM of Aβ could not be visualized, despite a significant decrease in cell viability at these Heparan sulfate mediates Aβ cytotoxicity concentrations (Figure 2) . On the other hand, the sensitivity of the immunocytochemical procedure used to visualize intracellular Aβ may be insufficient for detecting small yet significant amounts of toxic intracellular Aβ or Aβ conformations in which antibody epitopes are masked. These issues relate to the key question concerning the macromolecular state of the biologically active peptide species. Prefibrillar, oligomeric, soluble assemblies of Aβ have been implicated as the deleterious form of the peptide (Selkoe 2008; Walsh and Selkoe 2007) , and the toxic effects observed following administration of variously aggregated Aβ preparations may therefore reflect equilibria between different aggregation states (Jan et al. 2008) . If in fact oligomeric, but not fibrillar Aβ, is taken up by cells, as suggested (Chafekar et al. 2008) , small amounts of low MW Aβ40 aggregates generated from aa-Aβ40 at the cell surface may account for the observed HS-dependent cytotoxicity ( Figure 1C) .
Overexpression of heparanase, an endo-glucuronidase, in animals and cells results in degradation of HS (Escobar Galvis et al. 2007; Sandwall et al. 2009 ) and was found to confer resistance towards experimental AA amyloidosis in mice (Li et al. 2005) . To examine the impact of heparanase on Aβ cytotoxicity, we employed a HEK293 cell line overexpressing the enzyme (hpa-HEK293) and a control mock-transfected HEK293 cell line (Nasser et al. 2005) . Treatment of control cells with Aβ reduced viability by ∼50%, whereas hpa-HEK293 cells were relatively unaffected ( Figure 3B ). Previous studies on HS in murine liver overexpressing heparanase showed release of HS fragments, but also accelerated turnover of cell-surface HSPGs (Escobar Galvis et al. 2007) . Aβ toxicity could conceivably be modulated through interaction of Aβ with released HS fragments, but could also be due to interference with Aβ internalization normally dependent on regulated HSPG turnover. Vehicle functions for cell-surface HSPGs have been defined for a variety of endocytosis and transcytosis processes (Stanford et al. 2009; Williams and Fuki 1997) . Effects of HS fragments may be simulated by exogenous heparin, a highly sulfated HS analog, potentially capable of competing with cellsurface HS for Aβ binding and thus preventing the peptide from interacting with cells (Narindrasorasak et al. 1991 ). This has also been reported for internalization of the scrapie form of PrP into cells (Hijazi et al. 2005) . Protection of cells against Aβ by addition of heparin, as shown here for HUVEC cultures ( Figure 4A and B), has also been reported for hippocampal neuron cultures and the neuronal cell line PC12 (rat pheochromocytoma) (Bergamaschini et al. 2002; Pollack et al. 1995; Woods et al. 1995) . Again, coupling between Aβ internalization and its cellular toxicity was underpinned by the dual inhibitory effects of heparin in the HUVEC system (Figure 4) . We noted the size dependence of the protective effect of heparin, e.g.18-mer fragments were effective whereas 12-mers were not ( Figure 4B ). While our previous results showed that heparin fragments as short as 6-mers could bind fibrillar Aβ40 (Lindahl et al. 1999) , it seems that longer fragments are required to neutralize the cytotoxic effect of the peptide. In fact, enoxaparin, a low MW heparin of average 18-mer size, reduces Aβ accumulation and plaque burden in mice overexpressing human AβPP (Bergamaschini et al. 2004 ). Such size requirement should be explored in future strategies aiming at inhibiting Aβ cytotoxicity by heparin-related drugs. It may also provide further insight into the precise nature of the interaction between toxic Aβ species and HSPGs at the cell surface.
Materials and methods
Reagents
Aβ40 was synthesized at the Department of Medical Biochemistry and Microbiology Peptide Synthesis Facility, Uppsala University (Lindahl et al. 1999) . Different preparations of Aβ40, i.e. nonaggregated (na-Aβ), aggregated (a-Aβ) and aggregated-agitated (aa-Aβ) were used in the experiments. The na-Aβ was dissolved in distilled water at a concentration of 2 mM, aliquoted and used directly in the subsequent experiments or as the stock for a-and aa-Aβ. The a-Aβ and aa-Aβ were dissolved in distilled water at concentrations of 250 µM and 10 µM, respectively. a-Aβ was incubated for 168 h without agitation and aa-Aβ for 72 h with agitation at 37°C. Native polyacrylamide gel electrophoresis analysis revealed different degrees of peptide aggregation in the three samples (Supplementary Figure 1 ). Heparin was from Kabivitrum (Malmö, Sweden), and fragments were generated by partial degradation of the polysaccharide with HNO 2 at pH 1.5 (Shively 1976) , resulting in cleavage at N-sulfated glucosamine residues, and subsequently separated by gel chromatography on a Bio-Gel P10 column (GE Healthcare Biosciences, Uppsala, Sweden) as described (Maccarana et al. 1996) . Fractions of 6-, 12-and 18-mers were collected, desalted on PD-10 columns (GE Healthcare Biosciences) and lyophilized.
Cell culture HUVEC (American Type Culture Collection, LGC, Borås, Sweden) and HEK293 cells, mock and human heparanase transfected (Nasser et al. 2005) , were cultured in Dulbecco's modified eagle's medium (DMEM; Gibco, Invitrogen, Carlsbad, CA) supplemented with 10% fetal bovine serum (FBS), penicillin/streptomycin (60 and 50 µg/mL, respectively) (Invitrogen, Carlsbad, CA) at 37°C, 5% CO 2 . Wild-type (CHO-WT) and HS-deficient (CHO pgsD-677) CHO cells (Lidholt et al. 1992) were cultured in F12 medium (Gibco) supplemented with 10% FBS, penicillin/streptomycin (60 and 50 µg/mL, respectively). The cells were passaged 2-3 times/week.
GAG analysis CHO cells were grown in 75 cm
2 flasks to 90% confluence, then changed to fresh medium containing 800 µCi Na 2 35 SO 4 or 800 µCi [
3 H]glucosamine in 8 mL of medium and further cultured for 24 h. The cells were harvested, and the media were collected for isolation of HS. The cells were lysed by incubation in a lysis buffer (4 M Urea, 1% Triton X-100, 50 mM Tris-HCl pH 7.4, 0.25 M NaCl) at 4°C for 1 h, followed by alkali treatment in 0.5 M NaOH at 4°C overnight. After neutralization with 0.5 M HCl, the lysate was diluted 10× in the lysis buffer and applied to a 2-mL DEAE-Sephacel column (GE Healthcare Biosciences) equilibrated in the lysis buffer. The loaded column was first washed with 20 mL of lysis buffer followed by washing with 50 mM NaAc pH 4.5, 0.25 M NaCl until no radioactivity could be detected in the effluent. Bound material was eluted with 2 M NaCl in 50 mM NaAc buffer, pH 4.5, desalted on a PD-10 column (GE Healthcare Biosciences) and lyophilized. The sam-ples were analyzed by gel chromatography on a Superose 12 column before and after digestion with Chondroitinase ABC (Seikagaku, Tokyo, Japan; 0.2 U in 500 µL 50 mM Tris-HCl pH 8) for 24 h at 37°C. The purity of HS was also verified by nitrous acid cleavage at pH 1.5 as described (Shively and Conrad 1976) . In an alternative approach, chondroitinase-digested HS was isolated on a 0.5 mL DEAE (diethylaminoethyl)-Sephacel column as described above before analysis on a Superose 12 column.
Cell viability assay -MTT Cell viability was assessed using the MTT (Sigma Aldrich, Stockholm, Sweden) assay essentially as described (Mosmann 1983) . The cells (5000 cells/well) were seeded in 96-well plates and cultured for 48 h in DMEM or F12 medium fortified with 10% FBS. Culture medium was changed to fresh medium supplemented with 0.1% FBS containing Aβ peptide and/or heparin or heparin oligosaccharides at the concentrations indicated. After 24 h incubation, cell viability was evaluated through determination of MTT reduction. The reduced MTT product, a purple formazan generated by viable cells, was detected by its absorbance at 562 nm using a microplate reader. Decreased cell viability, resulting from Aβ exposure, was expressed as a percentage of the decrease in MTT reduction relative to the values recorded for untreated controls.
Flow cytometry
Apoptosis analysis was performed using the Vybrant Apoptosis Assay kit (Molecular Probes, Invitrogen, Carlsbad, CA). Cells were seeded at a density of 300,000 cells/well in a 6-well plate. After 24 h, the cell culture medium was changed to fresh F12 or DMEM medium supplemented with 0.1% FBS containing Aβ40 in the presence or absence of heparin as indicated in the figures. After overnight incubation, the cells were trypsinized and washed twice by centrifugation in cold phosphatebuffered saline (PBS). The cells were diluted in 100 µL of 1× annexin V binding buffer per assay followed by incubation with fluorescein isothiocyanate (FITC)-labeled annexin V and PI for 15 min at room temperature in the dark. Four hundred microliters of 1× annexin V binding buffer was added to the cells, which were then mixed gently and analyzed by flow cytometry. Ten thousand events were acquired per sample, and fluorescence emission signals for annexin V-FITC were plotted against PI to identify viable cells (i.e. negative for annexin V and PI signals), early apoptotic cells (annexin V signal only) and late apoptotic/necrotic cells (positive for annexin V and PI signals). Analysis was performed on a BD Biosciences LSRII instrument.
Immunocytochemistry
Cells were seeded at a density of 20,000/well in 8-well LabTec™ chambers (Nunc, Thermo Fisher Scientific, Roskilde, Denmark) or 50,000/well in 4-well chambers. After 24 h, the cell culture medium was changed to fresh DMEM or F12 medium supplemented with 0.1% FBS containing Aβ40 in the presence or absence of heparin as indicated in the figures. After overnight incubation, the cells were washed twice in PBS and fixed in 95% ethanol, 5% acetic acid for 5 min. The cells were washed with PBS and blocked with Vector M.O.M. kit (Vector Labs, Burlingame, CA) at room temperature. After additional PBS washing, the cells were permeabilized with 0.4% Triton X-100 and incubated with anti-Aβ antibodies 6E10 (Covance Inc., Princeton, NJ; 1 μg/mL) or 82E1 (EBL, Hamburg, Germany; 1 µg/mL in PBS) for 1 h at room temperature, followed by incubation with Alexa fluor™ 488/594 anti-mouse IgG (Molecular Probes; 8 μg/mL) for 1 h. When biotinylated, anti-mouse IgG (Vector Labs; 1:5000) was used; sections were treated with 3% H 2 O 2 in PBS for 15 min before primary antibody incubation, and immunosignals were developed with the NOVA Red chromogen kit (Vector Labs). Fluorescently stained slides were mounted with Vectashield (Vector Labs) containing the nuclear counterstain DAPI (4',6-diamidino-2-phenylindole). NOVA-red stained cells were counterstained with hematoxylin and mounted with DPX (distrene-80 plasticizer xylene; VWR, Stockholm, Sweden). Cross-sectional information and z-stacks of Aβ internalization were obtained by confocal laser scanning microscopy, using a Carl Zeiss LSM 510 META instrument and images were prepared using IMARIS software.
Image analysis
Multiple frames of 82E1 immunostained CHO-WT and CHO pgsD-677 culture wells were captured at 100× magnification (n = 3-7). Exposure time was constant and, to avoid overexposure, was determined by the well with the most intense immunofluorescence. The number of cells per captured frame was determined by ImageJ (http://rsb.info.nih.gov/ij/) particle analysis of DAPI-stained nuclei. The area of positive Aβ40 immunostaining per frame was recorded using a constant threshold range, and the background signal from untreated cells was set as baseline. The average area of Aβ immunosignal/cell for each of the captured frames was plotted against the concentration of na-Aβ40, to which the cells had been exposed.
Statistical analysis
Statistical significance was established by Student's t-tests, and P-values were represented as follows: *P<0.05, **P<0.01 and ***P<0.001.
Supplementary data
Supplementary data for this article is available online at http://glycob.oxfordjournals.org/.
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